Approaches and agents for imaging the vascular system

Advanced Drug Delivery Reviews

Volumn 37, Issue 1-3, 1999, Pages 279-293

  Bogdanov Jr , Alexei A ^a   Lewin, Maïté ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angiogenesis; Blood pool; Chelate; Contrast agent; Gadolinium; Graft co polymer; Imaging; Paramagnetic; Poly(ethylene glycol)

Indexed keywords

ANGIOGRAPHY; BLOOD VESSELS; COMPUTERIZED TOMOGRAPHY; CONTRAST MEDIA; GADOLINIUM; GRAFT COPOLYMERS; MAGNETIC RESONANCE IMAGING; MOLECULAR WEIGHT; NUCLEAR MEDICINE; PARAMAGNETISM; POLYETHYLENE GLYCOLS; PROTEINS;

ANGIOGENESIS; BLOOD POOL; LIPOSOME BASED BLOOD CELL MIMETICS; PARAMAGNETIC; PLASMA PROTEIN MIMETICS; RED BLOOD CELLS; VASCULAR SYSTEM;

CONTROLLED DRUG DELIVERY;

ALBUMIN; CETOMACROGOL; CHELATE; CONTRAST MEDIUM; COPOLYMER; DENDRIMER; DEXTRAN; DIAGNOSTIC AGENT; GADOLINIUM; GADOLINIUM PENTETATE; INDIUM 111; IOPROMIDE; IRON OXIDE; LIPOSOME; MACROGOL; PENTETATE TECHNETIUM TC 99M; PENTETIC ACID; PLASMA PROTEIN; POLYMER;

BLOOD; BLOOD CELL; CARDIOVASCULAR SYSTEM; CARDIOVASCULAR SYSTEM EXAMINATION; COLLOID; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; ERYTHROCYTE; HUMAN; IMAGING; MACROMOLECULE; MOLECULAR WEIGHT; NONHUMAN; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; REVIEW; TECHNIQUE;

EID: 0344958757     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00098-2     Document Type: Review

References (97)

1. H. Gupta, R. Weissleder, A.A. Bogdanov Jr., T.J. Brady, Experimental gastrointestinal hemorrhage: detection with contrast-enhanced MR imaging and scintigraphy, Radiology 196 (1995) 239-244.
2. H.C. Schwickert, D.M. Shames, C.F. van Dijke, J.S. Mann, M. Saeed, R.C. Brasch, An MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution, Magn. Reson. Med. 37 (1997) 236-242.
3. B.R. Buchbinder, G.R. Cosgrove, Cortical activation MR studies in brain disorders, Magn. Reson. Imaging Clin. North Am. 6 (1998) 67-93.
4. R. Callahan, M. Chilton, Radiopharmaceuticals for cardiac imaging, in: M.J. Guiberteau (Ed.), Nuclear Cardiovascular Imaging: Current Clinical Practice, Churchill Livingstone, New York, 1994, pp. 23-39.
5. S.C. Srivastava, L.R. Chervu, Radionuclide-labeled red blood cells: current status and future prospects, Semin. Nucl. Med. 14 (1984) 68-82.
6. N. Chilton, R. Callahan, J. Thrall, Radiopharmaceuticals for cardiac imaging: myocardial infarction, perfusion, metabolism, and ventricular function (blood pool), in: D.P. Swanson, H.M. Chilton, J.H. Thrall (Eds.), Pharmaceuticals in Medical Imaging, Macmillan, New York, 1990, p. 448.
7. E. Palmer, J. Scott, H. Strauss, Practical Nuclear Medicine, W.B. Saunders, Philadelphia, 1992, pp. 1-399.
8. V.J. Caride, W. Taylor, J.A. Cramer, A. Gottschalk, Evaluation of liposome-entrapped radioactive tracers as scanning agents. Part 1: organ distribution of liposome (99mTc-DTPA) in mice, J. Nucl. Med. 17 (1976) 1067-1072.
9. T.M. Allen, P. Williamson, R.A. Schlegel, Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface, Proc. Natl. Acad. Sci. USA 85 (1988) 8067-8071.
10. V.P. Torchilin, Polymer-coated long-circulating microparticulate pharmaceuticals, J. Microencaps. 15 (1998) 1-19.
11. T.M. Allen, Long-circulating (sterically stabilized) liposomes for targeted drug delivery, Trends Pharmacol. Sci. 15 (1994) 215-220.
12. M.C. Woodle, D.D. Lasic, Sterically stabilized liposomes, Biochim. Biophys. Acta. 1113 (1992) 171-199.
13. V. Torchilin, V. Trubetskoy, Which polymers can make nanoparticulate drug carriers long circulating? Adv. Drug Del. Rev. 16 (1995) 141-155.
14. V. Torchilin, V. Omelyanenko, M. Papisov, A. Bogdanov Jr., V.P. Trubetskoi, J.N. Herron, C.A. Gentry, Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity, Biochim. Biophys. Acta 1195 (1994) 11-20.
15. C. Tilcock, Q.F. Ahkong, D. Fisher, Polymer-derivatized technetium 99mTc-labeled liposomal blood pool agents for nuclear medicine applications, Biochim. Biophys. Acta 1148 (1993) 77-84.
16. C. Tilcock, M. Yap, M. Szucs, D. Utkhede, PEG-coated lipid vesicles with encapsulated technetium-99m as blood pool agents for nuclear medicine, Nucl. Med. Biol. 21 (1994) 165-170.
17. M. Szucs, C. Tilcock, Lyophilization and rehydration of polymer-coated lipid vesicles containing a lipophilic chelator in the presence of sucrose: labeling with 99mTc and biodistribution studies, Nucl. Med. Biol. 22 (1995) 263-268.
18. B. Goins, W.T. Phillips, R. Klipper, Blood-pool imaging using technetium-99m-labeled liposomes, J. Nucl. Med. 37 (1996) 1374-1379.
19. 67Gallium-labeled liposomes with prolonged circulation: preparation and potential as nuclear imaging agents, Nucl. Med. Biol. 20 (1993) 149-155.
20. S.E. Seltzer, M.A. Davis, D.F. Adams, P.M. Shulkin, W.J. Landis, A. Havron, Liposomes carrying diatrizoate. Characterization of biophysical properties and imaging applications, Invest. Radiol. 19 (1984) 142-151.
21. S. Benita, P.A. Poly, F. Puisieux, J. Delattre, Radiopaque liposomes: effect of formulation conditions on encapsulation efficiency, J. Pharm. Sci. 73 (1984) 1751-1755.
22. G.I. Jendrasiak, G.D. Frey, R.C. Heim Jr., Liposomes as carriers of iodolipid radiocontrast agents for CT scanning of the liver, Invest. Radiol. 20 (1985) 995-1002.
23. A. Sachse, J.U. Leike, T. Schneider, S.E. Wagner, G.L. Rossling, W. Krause, M. Brandl, Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying liposomes, Invest. Radiol. 32 (1997) 44-50.
24. R.W. Storrs, F.D. Tropper, H.Y. Li, C.K. Song, D.A. Sipkins, J.K. Kuniyoshi, M.D. Bednarski, H.W. Strauss, K.C. Li, Paramagnetic polymerized liposomes as new recirculating MR contrast agents, J. Magn. Reson. Imaging 5 (1995) 719-724.
25. C.W. Grant, S. Karlik, E. Florio, A liposomal MRI contrast agent: phosphatidylethanolamine-DTPA, Magn. Reson. Med. 11 (1989) 236-243.
26. S. Karlik, E. Florio, C.W. Grant, Comparative evaluation of two membrane-based liposomal MRI contrast agents, Magn. Reson. Med. 19 (1991) 56-66.
27. A.L. Alexander, T.T. McCreery, T.R. Barrette, A.F. Gmitro, E.C. Unger, Microbubbles as novel pressure-sensitive MR contrast agents, Magn. Reson. Med. 35 (1996) 801-806.
28. R. Weissleder, A. Bogdanov, E. Neuwelt, M. Papisov, Long-circulating iron oxides for MR imaging, Adv. Drug Del. Rev. 16 (1995) 321-334.
29. H. Frank, R. Weissleder, T.J. Brady, Enhancement of MR angiography with iron oxide: preliminary studies in wholeblood phantom and in animals, Am. J. Roentgenol. 162 (1994) 209-213.
30. S.J. McLachlan, M.R. Morris, M.A. Lucas, R.A. Fisco, M.N. Eakins, D.R. Fowler, R.B. Scheetz, A.Y. Olukotun, Phase I clinical evaluation of a new iron oxide MR contrast agent, J. Magn. Reson. Imaging 4 (1994) 301-307.
31. P. Loubeyre, S. Zhao, E. Canet, H. Abidi, S. Benderbous, D. Revel, Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: experimental study in rabbits, J. Magn. Reson. Imaging 7 (1997) 958-962.
32. F.D. Knollmann, J.C. Bock, S. Teltenkotter, W. Wlodarczyk, A. Muhler, T.J. Vogl, R. Felix, Evaluation of portal MR angiography using superparamagnetic iron oxide, J. Magn. Reson. Imaging 7 (1997) 191-196.
33. Y. Anzai, M.R. Prince, T.L. Chenevert, J.H. Maki, F. Londy, M. London, S.J. McLachlan, MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent, J. Magn. Reson. Imaging 7 (1997) 209-214.
34. S. Saini, R.R. Edelman, P. Sharma, W. Li, W. Mayo-Smith, G.J. Slater, P.J. Eisenberg, P.F. Hahn, Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227), Am. J. Roentgenol. 164 (1995) 1147-1152.
35. G.S. Gazelle, G.L. Wolf, G.L. McIntire, E.R. Bacon, E.F. Halpern, E.R. Cooper, J.L. Toner, Nanoparticulate computed tomography contrast agents for blood pool and liver-spleen imaging, Acad. Radiol. 1 (1994) 373-376.
36. K. Adzamli, R.B. Dorshow, M.R. Hynes, D. Li, D.L. Nosco, M.D. Adams, Preliminary evaluation of a polyethyleneglycol-stabilized manganese-substituted hydroxylapatite as an intravascular contrast agent for MR angiography, J. Magn. Reson. Imaging 7 (1997) 204-208.
37. K. Adzamli, R.B. Dorshow, M.R. Hynes, D.L. Nosco, M.D. Adams, Characterization of polyethyleneglycol-stabilized, manganese-substituted hydroxylapatite (MnHA-PEG). A potential MR blood pool agent, Acta Radiol. Suppl. 412 (1997) 73-78.
38. R.B. Lauffer, T.J. Brady, Preparation and water relaxation properties of proteins labeled with paramagnetic metal chelates, Magn. Reson. Imaging 3 (1985) 11-16.
39. 3+ protein-chelate conjugates, Magn. Reson. Med. 3 (1986) 541-548.
40. R.J. Callahan, K.A. McKusick, M. Lamson, F.P. Castronovo, M.S. Potsaid, Technetium-99m-human serum albumin: evaluation of a commercially produced kit, J. Nucl. Med. 17 (1976) 47-49.
41. J. Thrall, J. Freitas, D. Swanson, W.L. Rogers, J.M. Clare, M.L. Brown, B. Pitt, Clinical comparison of cardiac blood pool visualization with technetium-99m red blood cells labeled in vivo and technetium-99m human serum albumin, J. Nucl. Med. 19 (1978) 796-803.
42. A.-S. Hambye, K. Verbeke, R. Vandermeiren, E. Joosens, A. Verbruggen, M. DeRoo, Comparison of modified technetium-99m albumin and technetium-99m red blood cells for equilibrium ventriculography, J. Nucl. Med. 38 (1997) 1521-1526.
43. A.C. Perkins, M. Frier, Experimental biodistribution studies of 99mTc-recombinant human serum albumin (rHSA): a new generation of radiopharmaceutical, Eur. J. Nucl. Med. 21 (1994) 1231-1233.
44. H. Vanbilloen, K. Verbeke, M. De Roo, A. Verbruggen, Technetium-99m labelled human serum albumin for ventriculography: a comparative evaluation of six labelling kits, Eur. J. Nucl. Med. 20 (1993) 465-472.
45. K. Verbeke, H. Vanbilloen, M. De Roo, A. Verbruggen, Technetium-99m mercaptoalbumin as a potential substitute or technetium-99m labelled red blood cells, Eur. J. Nucl. Med. 20 (1993) 473-482.
46. K.A. Verbeke, W.B. Vanhecke, L.A. Mortelmans, A.M. Verbruggen, First evaluation of technetium-99m dimercaptopropionyl albumin as a possible tracer agent for ventriculography in a volunteer, Eur. J. Nucl. Med. 21 (1994) 906-912.
47. T. Nishimura, S. Hamada, K. Hayashida, T. Uehara, T. Katabuchi, M. Hayashi, Cardiac blood-pool scintigraphy using technetium-99m DTPA-HSA: comparison with in vivo technetium-99m RBC labeling, J. Nucl. Med. 30 (1989) 1713-1717.
48. A.B. Baxter, S. Melnikoff, D.P. Stites, R.C. Brasch, Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging. Induction and characterization of antibodies in animals, Invest. Radiol. 26 (1991) 1035-1040.
49. A.A. Bogdanov Jr., R. Weissleder, H.W. Frank, A.V. Bogdanova, N. Nossif, B.K. Schaffer, E. Tsai, M.I. Papisov, T.J. Brady, A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies, Radiology 187 (1993) 701-706.
50. M.D. Ogan, U. Schmiedl, M.E. Moseley, W. Grodd, H. Paajanen, R.C. Brasch, Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization, Invest. Radiol. 22 (1987) 665-671.
51. R. Lauffer, Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design, Chem. Rev. 87 (1987) 901-927.
52. R. Brasch, Rationale and applications for macromolecular Gd-based contrast agents, Magn. Reson. Med. 22 (1991) 282-287.
53. U.P. Schmiedl, K.R. Maravilla, J.A. Nelson, Improved method for in vivo magnetic resonance contrast media research, Invest. Radiol. 26 (1991) 65-70.
54. G. Schuhmann-Giampieri, H. Schmitt-Willich, T. Frenzel, W.R. Press, H.J. Weinmann, In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging, Invest. Radiol. 26 (1991) 969-974.
55. G. Marchal, H. Bosmans, P. Van Hecke, U. Speck, P. Aerts, P. Vanhoenacker, A.L. Baert, MR angiography with gadopentetate dimeglumine-polylysine: evaluation in rabbits, Am. J. Roentgenol. 155 (1990) 407-411.
56. G. Marchal, H. Bosmans, P. Van Hecke, Y.B. Jiang, P. Aerts, B. Bauer, Experimental Gd-DTPA polylysine enhanced MR angiography: sequence optimization, J. Comput. Assist. Tomogr. 15 (1991) 711-715.
57. P. Van Hecke, G. Marchal, H. Bosmans, K. Johannik, Y. Jiang, H. Vogler, C. Van Ongeval, A.L. Baert, U. Speck, NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat, Magn. Reson. Imaging 9 (1991) 313-321.
58. Y. Berthezene, V. Vexler, H. Jerome, R. Sievers, M. Moseley, R. Brasch, Differentiation of capillary leak and hydrostatic pulmonary edema with a macromolecular MR imaging contrast agent, Radiology 181 (1991) 773-777.
59. Y. Berthezene, V. Vexler, D.C. Price, J. Wisner-Dupon, M.E. Moseley, K.P. Aicher, R.C. Brasch, Magnetic resonance imaging detection of an experimental pulmonary perfusion deficit using a macromolecular contrast agent. Polylysine-gadolinium-DTPA40, Invest. Radiol. 27 (1992) 346-351.
60. Y. Berthezene, V. Vexler, O. Clement, A. Muhler, M.E. Moseley, R.C. Brasch, Contrast-enhanced MR imaging of the lung: assessments of ventilation and perfusion, Radiology 183 (1992) 667-672.
61. Y. Berthezene, V. Vexler, R. Kuwatsuru, W. Rosenau, A. Muhler, O. Clement, D.C. Price, R.C. Brasch, Differentiation of alveolitis and pulmonary fibrosis with a macromolecular MR imaging contrast agent, Radiology 185 (1992) 97-103.
62. J.C. Bock, U. Pison, F. Kaufmann, R. Felix, Gd-DTPA-polylysine-enhanced pulmonary time-of-flight MR angiography, J. Magn. Reson. Imaging 4 (1994) 473-476.
63. V. Vexler, Y. Berthezene, O. Clement, A. Muhler, W. Rosenau, M.E. Moseley, R.C. Brasch, Detection of zonal renal ischemia with contrast-enhanced MR imaging with a macromolecular blood pool contrast agent, J. Magn. Reson. Imaging 2 (1992) 311-319.
64. M. Saeed, M. Wendland, T. Masui, A.J. Connolly, N. Derugin, R.C. Brasch, C.B. Higgins, Myocardial infarction: assessment with an intravascular MR contrast medium. Work in progress, Radiology 180 (1991) 153-160.
65. V.S. Vexler, Y. Berthezene, C.L. Wolfe, R. Sievers, J.W. Dupon, K. Aicher, M.E. Moseley, R.C. Brasch, Magnetic resonance imaging demonstration of pharmacologic-induced myocardial vasodilatation using a macromolecular gadolinium contrast agent, Invest. Radiol. 27 (1992) 935-941.
66. V.S. Vexler, O. Clement, H. Schmitt-Willich, R.C. Brasch, Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns, J. Magn. Reson. Imaging 4 (1994) 381-388.
67. E. Henze, G.D. Robinson, D.E. Kuhl, H.R. Schelbert, Tc-99m dextran: a new blood-pool-labeling agent for radionuclide angiocardiography, J. Nucl. Med. 23 (1982) 348-353.
68. F.E. Armitage, D.E. Richardson, K.C. Li, Polymeric contrast agents for magnetic resonance imaging: synthesis and characterization of gadolinium diethylenetriaminepentaacetic acid conjugated to polysaccharides, Bioconj. Chem. 1 (1990) 365-374.
69. S.C. Wang, M.G. Wikstrom, D.L. White, J. Klaveness, E. Holtz, P. Rongved, M.E. Moseley, R.C. Brasch, Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues, Radiology 175 (1990) 483-488.
70. D. Revel, C. Chambon, P. Havard, G. Dandis, E. Canet, C. Corot, M. Amiel, Iodinated polymer as blood-pool contrast agent. Computed tomography evaluation in rabbits, Invest. Radiol. 26 (1991) S57.
71. P. Rongved, J. Klaveness, Water-soluble polysaccharides as carriers of paramagnetic contrast agents for magnetic resonance imaging: synthesis and relaxation properties, Carbohydr. Res. 214 (1991) 315-323.
72. M. Wikstrom, H.J. Martinussen, G. Wikstrom, A. Ericsson, R. Nyman, A. Waldenstrom, A. Hemmingsson, MR imaging of acute myocardial infarction in pigs using Gd-DTPA-labeled dextran, Acta Radiol. 33 (1992) 301-308.
73. K.C. Li, R.G. Quisling, F.E. Armitage, D. Richardson, C. Mladinich, In vivo MR evaluation of Gd-DTPA conjugated to dextran in normal rabbits, Magn. Reson. Imaging 10 (1992) 439-444.
74. P. Loubeyre, E. Canet, S. Zhao, S. Benderbous, M. Amiel, D. Revel, Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits, Invest. Radiol. 31 (1996) 288-293.
75. C. Corot, M. Schaefer, S. Beaute, P. Bourrinet, S. Zehaf, V. Benize, M. Sabatou, D. Meyer, Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer, Acta Radiol. Suppl. 412 (1997) 91-99.
76. R. Rebizak, M. Schaefer, E. Dellacherie, Polymeric conjugates of Gd(3+)-diethylenetriaminepentaacetic acid and dextran. 1. Synthesis, characterization, and paramagnetic properties, Bioconj. Chem. 8 (1997) 605-610.
77. R. Rebizak, M. Schaefer, E. Dellacherie, Polymeric conjugates of Gd(3+)-diethylenetriaminepentaacetic acid and dextran. 2. Influence of spacer arm length and conjugate molecular mass on the paramagnetic properties and some biological parameters, Bioconj. Chem. 9 (1998) 94-99.
78. B. Kulik, T. Fritz, E. Unger, P. Hallaway, P. Dragsten, B. Hedlund, Hydroxyethyl starch-ferrioxamine: a potential MR contrast agent for diagnosis of hepatic metastasis, 11th Ann. Mtg. Soc. Magn. Reson. Med., SMRM, Berkeley, CA, 1992, p. 3245.
79. G. Tian, J. Shen, S. Su, P. Kozlowski, J. Sun, B. Xiang, J.K. Saunders, R. Deslauriers, Evaluation of hydroxyethyl-starch-ferrioxamine as an intravascular MR contrast agent for assessment of myocardial perfusion, Acta Radiol. 38(Suppl. 412) (1997) 85-90.
80. E. Unger, D. Shen, G. Wu, T.A. Fritz, B. Kulik, D. Palestrant, G. Blatner, T.E. New, Copolymeric magnetic resonance contrast agents, 11th Ann. Mtg. Soc. Magn. Reson. Med., SMRM, Berkeley, CA, 1992, p. 1405.
81. W.A. Gibby, A. Bogdan, T. Ovitt, Cross-linked DTPA polysaccharides for magnetic resonance imaging. Synthesis and relaxation properties, Invest. Radiol. 4 (1989) 302-309.
82. W.A. Gibby, J. Billings, J. Hall, T. Ovitt, Biodistribution and magnetic resonance imaging of cross-linked DTPA polysaccharides, Invest. Radiol. 25 (1990) 164-172.
83. G. Adam, J. Neuerburg, E. Spuntrup, A. Muhler, K. Scherer, R.W. Gunther, Gd-DTPA-cascade-polymer: potential blood pool contrast agent for MR imaging, J. Magn. Reson. Imaging 4 (1994) 462-466.
84. E. Weiner, M. Brechbiel, H. Brothers, R.L. Magin, O.A. Gansow, D.A. Tomalia, P.C. Lauterbur, Dendrimer-based metal chelates: a new class of magnetic resonance imaging agents, Magn. Reson. Med. 31 (1994) 1-8.
85. H.C. Schwickert, T.P. Roberts, A. Muhler, M. Stiskal, F. Demsar, R.C. Brasch, Angiographic properties of Gd-DTPA-24-cascade-polymer - a new macromolecular MR contrast agent, Eur. J. Radiol. 20 (1995) 144-150.
86. A.A. Bogdanov Jr., R.J. Callahan, R.A. Wilkinson, C. Martin, J.A. Cameron, A.J. Fischman, T.J. Brady, R. Weissleder, Synthetic copolymer kit for radionuclide blood-pool imaging, J. Nucl. Med. 35 (1994) 1880-1886.
87. R. Callahan, A. Bogdanov Jr., A.J. Fischman, T.J. Brady, R. Weissleder, Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging, Am. J. Roentgenol. 171 (1998) 137-143.
88. A. Bogdanov Jr., S.C. Wright, E.M. Marecos, A. Bogdanova, C. Martin, P. Petherick, R. Weissleder, A long-circulating co-polymer in 'passive targeting' to solid tumors, J. Drug Target. 4 (1997) 321-330.
89. M.G. Traber, C.A. Thellman, M.J. Rindler, H.J. Kayden, Uptake of intact TPGS (D-alpha-tocopheryl polyethylene glycol 1000 succinate) a water-miscible form of vitamin E by human cells in vitro, Am. J. Clin. Nutr. 48 (1998) 605-611.
90. S. Zalipsky, R. Seltzer, S. Menon-Rudolph, Evaluation of a new reagent for covalent attachment of polyethylene glycol to proteins, Biotechnol. Appl. Biochem. 15 (1992) 100-114.
91. H. Frank, R. Weissleder, A.A. Bogdanov Jr., T.J. Brady, Detection of pulmonary emboli by using MR angiography with MPEG-PL-GdDTPA: an experimental study in rabbits, Am. J. Roentgenol. 162 (1994) 1041-1046.
92. H. Okuda, R. Nunes, S. Vallabhajosula, A. Strashun, S. Goldsmith, P. Berk, Studies of the hepatobiliary scintiscanning agent Tc-DISIDA, J. Hepatol. 3 (1986) 251-254.
93. R. Lauffer, Magnetic resonance contrast media: principles and progress, Magn. Reson. Q. 6 (1990) 65-84.
94. G. Schuhmann-Giamperi, H. Schmitt-Willich, W.R. Press, C. Negishi, H.J. Weinmann, U. Speck, Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system, Radiology 183 (1992) 59-64.
95. R. Walowitch, T. McMurry, Z. Tyeklar, D.M. Scott, P.J. Bernard, D.J. Parmalee, H.S. Quellet, S. Vallabhajosula, R.B. Lauffer, Biodistribution and safety studies of MS-264, a new liver agent with high hepatobiliary specificity, in: Proc. 2nd Ann. Mtg. Soc. Magn. Reson., SMRM, Berkeley, CA, 1994, p. 367.
96. R. Lauffer, D. Parmelee, S. Dunham, H.S. Quellet, R.P. Dolan, S. Witte, T.J. McCurry, R.C. Walovitch, MS-325: albumin-targeted contrast agent for MR angiography, Radiology 207 (1998) 529-538.
97. T. Grist, F. Korosec, D. Peters, S. Witte, R.C. Walovitch, R.P. Dolan, W.E. Bridson, E.K. Yucel, C.A. Mistretta, Steady-state and dynamic MR angiography with MS-325: initial experience in humans, Radiology 207 (1998) 539-544.